sma-therapy

BilkenTR-UNAM

October 21, 2023
sma-therapy, self-amplifying-rna-platform, spinal-muscular-atrophy
therapeutics

BilkenTR-UNAM # Revolutionizing SMA Therapy: A Self-Amplifying RNA Platform for Innovative Treatment # Our iGEM 2023 initiative targets the pressing challenges of Spinal Muscular Atrophy (SMA), a debilitating condition causing muscle weakness and atrophy. With our nation’s SMA prevalence twice the global average, the economic strain of current treatments necessitates new solutions. 当社のiGEM 2023のイニシアチブは、筋力の弱化と萎縮を引き起こす重大な病状である脊髄性筋萎縮症（SMA）の喫緊の課題を対象にしています。我が国のSMAの有病率は世界平均の2倍であり、現行の治療法の経済的な負担は新たな解決策を必要としています。 reference: iGEM BilkenTR-UNAM Team Information iGEM BilkenTR-UNAM Wiki